This inventor holds 1 USPTO granted patent. Top assignees: Southern Methodist University, The University of Texas System. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: Shashidhar Kumar Akubathini: Innovator in Neurodegenerative Therapeutics
Introduction
Shashidhar Kumar Akubathini is a notable inventor based in Karimnagar, India. He has made significant contributions to the field of therapeutic drugs, particularly in the treatment of neurodegenerative conditions. His innovative work focuses on developing compounds that can potentially alter the course of debilitating diseases.
Latest Patents
Shashidhar Kumar Akubathini holds a patent for "1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions." This invention includes compositions and methods aimed at inhibiting kinase activity to protect against neurodegeneration. The therapeutic applications target diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as conditions like ischemic stroke. The method involves providing a subject with a therapeutically effective amount of 1,4-benzoxazine compounds and derivatives thereof. He has been credited with 1 patent.
Career Highlights
Throughout his career, Shashidhar has worked with esteemed institutions, including the University of Texas System and Southern Methodist University. His experience in these organizations has allowed him to collaborate with leading experts in the field of neurodegenerative research.
Collaborations
Some of his notable coworkers include Santosh R D'Mello and Edward R Biehl. Their collaborative efforts have contributed to advancing research in therapeutic solutions for neurodegenerative diseases.
Conclusion
Shashidhar Kumar Akubathini's innovative work in developing therapeutic drugs for neurodegenerative conditions highlights his commitment to improving health outcomes. His contributions to the field are significant and pave the way for future advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile